Welcome to Dividends Inside
Welcome to Dividends Inside!

The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.

Kilroy Realty Corporation

KRC
$34.25 (+ $0.83 + 2.48%)
Last updated: 2026-05-21 00:37 UTC
KRC Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorReal Estate
IndustryREIT - Office
ISINUS49427F1084
Market Price34.25
Dividend Yield 6.0%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend 2.0
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyQuarterly
P/E Ratio14.02
EPS2.71
Market Cap$4.5B
Book Value46.2
Price to Book0.823
Beta1.08
52w High45.03
52w Low27.07
Next Earnings DateN/A
About the Company
Kilroy is a leading U.S. landlord and developer, with operations in San Diego, Los Angeles, the San Francisco Bay Area, Seattle, and Austin. The Company has earned global recognition for sustainability, building operations, innovation, and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the Company's approach to modern business environments helps drive creativity and productivity for some of the world's leading technology, entertainment, life science, and business services companies. The Company is a publicly traded real estate investment trust (“REIT”) and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring, and managing office, life science, and mixed-use projects. As of June 30, 2025, Kilroy's stabilized portfolio totaled approximately 16.4 million square feet of primarily office and life science space that was 80.8% occupied and 83.5% leased. The Company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 93.8%. In addition, the Company had one development project in the tenant improvement phase totaling approximately 875,000 square feet with a total estimated investment of $1.0 billion and two life science redevelopment projects in the tenant improvement phase totaling approximately 100,000 square feet with total estimated redevelopment costs of $85.0 million.
Price History